Tag - KLRS

Executive Moves

Laurie Keating joins Kalaris BOD

Kalaris Therapeutics (NASDAQ: KLRS) has announced the appointment of Laurie Keating to its board of directors (BOD), effective August 1, 2026, and the departure of Morana Jovan-Embiricos from the board. Ms. Keating...

July 7, 2026

Executive Moves

Leone Patterson joins Kalaris as BOD chair of audit committee

Kalaris Therapeutics (NASDAQ:KLRS) announced the appointment of Leone Patterson to its board of directors (BOD) as chair of the audit committee. Ms. Patterson brings extensive experience as a biotech executive and board...

April 4, 2025

Tag - KLRS

Laurie Keating joins Kalaris BOD

Leone Patterson joins Kalaris as BOD chair of audit committee

Subscribe